What oxygen flow is typically used with a nasal cannula in aeromedical patients, and what SpO₂ target should guide therapy?

What oxygen flow is typically used with a nasal cannula in aeromedical patients, and what SpO₂ target should guide therapy?

• A. 2–6 L/min; target SpO₂ 94–98% (or per protocol; COPD may be 88–92%)
• B. 1–4 L/min; target SpO₂ 92–96%
• C. 4–6 L/min; target SpO₂ 97–100%
• D. 2–8 L/min; target SpO₂ 90–92%

Answer: (A)

Low-flow oxygen via a nasal cannula in aeromedical patients is used to keep arterial oxygenation adequate without driving unnecessary high FiO2. The typical approach is a flow of 2–6 L/min, which provides a reliable increase in inspired oxygen without the complexity of higher-flow systems. The SpO2 target is usually around 94–98% (or per protocol), with a COPD exception often set at 88–92% to avoid depressing the patient’s driven ventilation. This balance keeps tissue oxygenation sufficient during flight, where ambient oxygen is lower than at sea level, while avoiding oxygen levels that could cause harm or CO2 retention in susceptible individuals. Other options either propose flows outside common practice or targets that are too high or too low for standard aeromedical care, making them less appropriate for typical nasal cannula therapy in flight.

Low-flow oxygen via a nasal cannula in aeromedical patients is used to keep arterial oxygenation adequate without driving unnecessary high FiO2. The typical approach is a flow of 2–6 L/min, which provides a reliable increase in inspired oxygen without the complexity of higher-flow systems. The SpO2 target is usually around 94–98% (or per protocol), with a COPD exception often set at 88–92% to avoid depressing the patient’s driven ventilation. This balance keeps tissue oxygenation sufficient during flight, where ambient oxygen is lower than at sea level, while avoiding oxygen levels that could cause harm or CO2 retention in susceptible individuals. Other options either propose flows outside common practice or targets that are too high or too low for standard aeromedical care, making them less appropriate for typical nasal cannula therapy in flight.